The purpose of this study is to evaluate the evolution of the symptoms of acute viral conjunctivitis using preservative free ketorolac trometamol 0.45% associated with carboxymethylcellulose compared with isolated use of preservative-free artificial tears.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in ocular symptoms from baseline to treatment day 7
Timeframe: 7 days
Change in ocular signs from baseline to treatment day 7
Timeframe: 7 days